Fewer antibiotics make more economic sense

Antibiotic alternatives, both as antibiotic growth promoters and therapeutics, are often seen as effective but expensive, so they are only applied on explicit demands from consumers or governance. Yet, in terms of return on investment good antibiotic alternatives deliver much more than disease management. In healthy animals antibiotics deliver no value, but alternatives still bring benefits. In the area of antibiotic resistance evaluating alternatives to antibiotics is not an option but obligat